Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from Chordia Therapeutics Inc. ( (JP:190A) ).
Chordia Therapeutics Inc. reported its financial results for the fiscal year ending August 31, 2025, showing a slight improvement in losses compared to the previous year. The company’s total assets and net assets decreased significantly, indicating potential challenges in financial stability and operational efficiency.
More about Chordia Therapeutics Inc.
Chordia Therapeutics Inc. is a company listed on the Tokyo Stock Exchange, operating in the pharmaceutical industry. It focuses on developing therapeutic solutions, although specific products or market focus details are not provided in the release.
Average Trading Volume: 852,988
Technical Sentiment Signal: Sell
Current Market Cap: Yen8.38B
Find detailed analytics on 190A stock on TipRanks’ Stock Analysis page.